Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
52,953 Cancer
clinical trials

Oncology Clinical Trial
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
476
mi
from 43215
Hackensack, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
340
mi
from 43215
Lutherville, MD
Click here to add this to my saved trials
Oncology Clinical Trial
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
420
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
166
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Oncology Clinical Trial
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
563
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Oncology Clinical Trial
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
1639
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
2102
mi
from 43215
Palo Alto, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
2007
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
3101
mi
from 43215
Anchorage, AK
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
361
mi
from 43215
Chattanooga, TN
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
616
mi
from 43215
Kansas City, MO
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
438
mi
from 43215
Lawrenceville, NJ
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
628
mi
from 43215
Lenexa, KS
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
330
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
430
mi
from 43215
Mount Laurel, NJ
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
483
mi
from 43215
Newburgh, NY
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
1958
mi
from 43215
Orange, CA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
490
mi
from 43215
Poughkeepsie, NY
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer
Status: Enrolling, Phase
Updated: 5/1/2018
1970
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluating the Effect of Perioperative Caloric Restriction Program on Perioperative Outcomes in Patients With Obesity and Endometrial Cancer
Status: Enrolling
Updated: 12/31/1969
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Solid Tumors Clinical Trial
A Phase 1 Trial of a Novel XPO1 Inhibitor in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
333
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Solid Tumors Clinical Trial
A Phase 1 Trial of a Novel XPO1 Inhibitor in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors
Status: Enrolling, Phase II
Updated: 2/15/2018
1970
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer
Status: Enrolling, Phase I, II
Updated: 7/25/2017
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL
Status: Enrolling, Phase I, II
Updated: 12/31/1969
344
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy
Status: Enrolling, Phase II
Updated: 4/9/2018
353
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Oncology Clinical Trial
CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy
Status: Enrolling
Updated: 2/6/2018
2102
mi
from 43215
Palo Alto, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Active Breathing Coordinator-based vs VisionRT-based Deep Inspiration Breath-hold for Radiation for Breast Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Advanced Solid Cancers Clinical Trial
AGEN-1884, an Anti-CTLA-4 Antibody, in Advanced Solid Cancers
Status: Enrolling, Phase I
Updated: 5/1/2017
348
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer
Status: Enrolling
Updated: 12/31/1969
624
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, Dose-Escalation, Safety Study of INCAGN01876 in Subjects With Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label, Dose-Escalation, Safety Study of INCAGN01876 in Subjects With Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Brain Cancer Clinical Trial
Pilot Trial of Dose-Volume Constraints for Reirradiation of Recurrent Brain Tumors
Status: Enrolling
Updated: 12/31/1969
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
Status: Enrolling, Phase II
Updated: 4/11/2018
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
Status: Enrolling, Phase II
Updated: 4/11/2018
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Oncology Clinical Trial
MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy Treatment
Status: Enrolling, Phase
Updated: 12/31/1969
312
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling, Phase
Updated: 4/5/2018
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling, Phase
Updated: 4/5/2018
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling, Phase
Updated: 4/5/2018
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling, Phase
Updated: 4/5/2018
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling, Phase
Updated: 4/5/2018
249
mi
from 43215
Roanoke, VA
Click here to add this to my saved trials
Neuroendocrine Tumors Clinical Trial
EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx
Status: Enrolling, Phase
Updated: 4/5/2018
2109
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Nephrology / Urology, Oncology Clinical Trial
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
Status: Enrolling
Updated: 12/31/1969
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
Status: Enrolling, Phase II
Updated: 8/4/2016
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
NASOPHARYNGEAL CARCINOMA Clinical Trial
A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
2101
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
Hematology, Oncology, Rheumatology, Reproductive Clinical Trial
Ovarian Tissue Freezing For Fertility Preservation In Women Facing A Fertility Threatening Medical Diagnosis/Treatment
Status: Enrolling
Updated: 12/31/1969
154
mi
from 43215
Lexington, KY
Click here to add this to my saved trials
Hematology, Oncology, Rheumatology, Reproductive Clinical Trial
Ovarian Tissue Freezing For Fertility Preservation In Women Facing A Fertility Threatening Medical Diagnosis/Treatment
Status: Enrolling
Updated: 12/31/1969
184
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
Cancer of Pancreas Clinical Trial
Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 12/31/1969
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Early Stage Breast Cancer Clinical Trial
Phase I Dose Escalation of Single Fraction Adjuvant Stereotactic Body Partial Breast Irradiation Early Stage Breast CA
Status: Enrolling, Phase I
Updated: 12/31/1969
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects
Status: Enrolling, Phase I
Updated: 12/31/1969
909
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
873
mi
from 43215
Sarasota, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
328
mi
from 43215
Washington DC,
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
A Dose Escalation Trial of SBRT After Induction Chemotherapy for Locally Advanced Pancreatic Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
1158
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated: 10/27/2017
909
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Solid Tumor Clinical Trial
A Study of LY3200882 in Participants With Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Solid Tumor Clinical Trial
A Study of LY3200882 in Participants With Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
Neoplasms Clinical Trial
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers
Status: Enrolling, Phase I, II
Updated: 12/31/1969
166
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling, Phase III
Updated: 12/31/1969
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling, Phase III
Updated: 12/31/1969
992
mi
from 43215
Galveston, TX
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling, Phase III
Updated: 12/31/1969
1333
mi
from 43215
Albuquerque, NM
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling, Phase III
Updated: 12/31/1969
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling, Phase III
Updated: 12/31/1969
1979
mi
from 43215
Beverly Hills, CA
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling, Phase III
Updated: 12/31/1969
166
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling, Phase III
Updated: 12/31/1969
183
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling, Phase III
Updated: 12/31/1969
1514
mi
from 43215
Murray, UT
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling, Phase III
Updated: 12/31/1969
1950
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Status: Enrolling, Phase III
Updated: 12/31/1969
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
501
mi
from 43215
Germantown, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
406
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
Phase I/II Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
Phase I/II Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
339
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder
Status: Enrolling, Phase I, II
Updated: 12/31/1969
484
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
741
mi
from 43215
Augusta, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
210
mi
from 43215
Kalamazoo, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
2007
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
3101
mi
from 43215
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
427
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
342
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
197
mi
from 43215
Bardstown, KY
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
801
mi
from 43215
Baton Rouge, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
800
mi
from 43215
Baton Rouge, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
797
mi
from 43215
Baton Rouge, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
131
mi
from 43215
Beachwood, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
2020
mi
from 43215
Bremerton, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
485
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
407
mi
from 43215
Bryn Mawr, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
637
mi
from 43215
Burlington, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
428
mi
from 43215
Carthage, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
65
mi
from 43215
Centerville, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
687
mi
from 43215
Chanute, KS
Click here to add this to my saved trials